Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization.
Liu W, Rong Y, Wang J, Zhou Z, Ge X, Ji C, Jiang D, Gong F, Li L, Chen J, Zhao S, Kong F, Gu C, Fan J, Cai W. · 2020
Read Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. by Liu W, Rong Y, Wang J, Zhou Z, Ge X, Ji C, Jiang D, Gong F, Li L, Chen J, Zhao S, Kong F, Gu C, Fan J, Cai W. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7001326.txt.
Introduction
Liu and co-authors show that low-oxygen training makes stem cell parcels heal spinal cord injury better. Their study appeared in the Journal of Neuroinflammation. Spinal cord injury causes severe loss of movement and feeling. Exosomes from mesenchymal stem cells already aid recovery in animals.
Stem cells in the body live in low oxygen, unlike lab culture. The team compared exosomes from oxygen-starved cells with normal ones in injured mice. The low-oxygen parcels restored behaviour better. They worked by flipping spinal immune cells, microglia, from an inflammatory M1 state to a healing M2 state. A small RNA, miR-216a-5p, was richest in the better parcels. It targets a gene called TLR4, feeding into known inflammatory cascades. Preconditioning in low oxygen, the authors conclude, is a practical way to upgrade cell-free therapy.
Catalog record
| CREATOR | Liu W, Rong Y, Wang J, Zhou Z, Ge X, Ji C, Jiang D, Gong F, Li L, Chen J, Zhao S, Kong F, Gu C, Fan J, Cai W. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 99 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization By Wei Liu, Yuluo Rong, Jiaxing Wang, Zheng Zhou, Xuhui Ge, Chengyue Ji, Dongdong Jiang, Fangyi Gong, Linwei Li, Jian Chen, Shujie Zhao, Fanqi Kong Published in: Journal of Neuroinflammation DOI: 10.1186/s12974-020-1726-7 ABSTRACT Abstract Background Spinal cord injury (SCI) can lead to severe motor and sensory dysfunction with high disability and mortality. In recent years, mesenchymal stem cell (MSC)-secreted nano-sized exosomes have shown great potential for promoting functional behavioral recovery following SCI. However, MSCs are usually exposed to normoxia in vitro, which differs greatly from the hypoxic micro-environment in vivo. Thus, the main purpose of this study was to determine whether exosomes derived from MSCs under hypoxia (HExos) exhibit greater effects on functional behavioral recovery than those under normoxia (Exos) following SCI in mice and to seek the underlying mechanism. Methods Electron microscope, nanoparticle tracking analysis (NTA), and western blot were applied to characterize differences between Exos and HExos group. A SCI model in vivo and a series of in vitro experiments were performed to compare the therapeutic effects between the two groups. Next, a miRNA microarray analysis was performed and a series of rescue experiments were conducted to verify the role of hypoxic exosomal miRNA in SCI. Western blot, luciferase activity, and RNA-ChIP were used to investigate the underlying mechanisms. Results Our results indicate that HExos promote functional behavioral recovery by shifting microglial polarization from M1 to M2 phenotype in vivo and in vitro. A miRNA array showed miR-216a-5p to be the most enriched in HExos and potentially involved in HExos-mediated microglial polarization. TLR4 was identified as the target downstream gene of miR-216a-5p and the miR-216a-5p/TLR4 axis was confirmed by a series of gain- and loss-of-function experiments. Finally, we found that TLR4/NF-κB/PI3K/AKT signaling cascades may be involved in the modulation of microglial polarization by hypoxic exosomal miR-216a-5p. Conclusion Hypoxia preconditioning represents a promising and effective approach to optimize the therapeutic actions of MSC-derived exosomes and a combination of MSC-derived exosomes and miRNAs may present a minimally invasive method for treating SCI. Keywords: Spinal cord injury, Exosomes, Hypoxia, Microglia polarization, miR-216a-5p/TLR4 axis BACKGROUND Traumatic spinal cord injury (SCI), with high morbidity and mortality, remains a devastating problem worldwide [1]. It is estimated that the mortality rate of hospitalized acute SCI ranges from 4.4 to 16.7% globally. With the aging population, the number of recorded cases of traumatic SCI caused by falls has increased from 16 to 30.5% since 2012 [2, 3]. Patients often suffer from lasting cognitive or motor dysfunction following SCI that has a devastating effect on their ability to continue with normal life [4]. Primary damage of the spinal cord is related to the destruction of axons and neurons, while secondary damage is caused by neuroinflammation, which can lead to edema, cavitation, and reactive gliosis morphologically [5–8]. At present, long-term treatments mainly deal with symptoms of secondary complications, such as serious neuroinflammation and poor adaptive plasticity following secondary damage [9]. However, because of the blood-brain barrier (BBB), until recently, very few therapeutic drugs or other interventions have been verified to inhibit the development of secondary damage and effectively promote functional recovery after SCI [10]. Following SCI, as one of the main resident cells in the central nervous system (CNS), microglia mediate a cascade of events and play a vital role in the activation and regulation of neuroinflammation [11, 12]. They exert dual effects on neuroinflammation and neurogenesis, depending on their polarization: the classical M1 phenotype secretes pro-inflammatory cytokines including TNF-α, IL-6, and IL-1β, which are harmful to neurogenesis. The alternative M2 phenotype secretes anti-inflammatory cytokines including TGF-β, IL-10, and IL-4, which are favorable to neurogenesis [13, 14]. Thus, efforts should focus on exploring therapeutic strategies to shift microglia from M1 to M2 phenotype as well as suppress detrimental excessive neuroinflammation for the treatment of SCI [15, 16]. Transplantation of mesenchymal stem cells (MSCs) shows therapeutic effects in SCI [17–19]. However, limitations and challenges cannot be ignored when transplanting MSCs directly into target tissues. Studies have reported that the survival rate of transplanted stem cells is very low. Other related risks including immune rejection, cell dedifferentiation, and tumor formation and these limit the underlying application of direct clinical MSC transplantation [20–22]. Recent studies investigating the role of MSCs in tissue regeneration have shown that paracrine mechanisms may be involved in the underlying MSC action mechanism in the treatment of several diseases and exosomes may play an important role in this process [23, 24]. Exosomes are nano-sized liposomes that originate from invagination of endosomal membranes and are important components of the paracrine secretion of cells [25]. They are formed from multivesicular bodies with a diameter of 50–150 nm and are released into the extracellular space through fusion with plasma membranes, while protecting their contents from degradation. They participate in the transport of biochemicals such as proteins, cytokines, mRNAs, and miRNAs and, as a result, play an essential role in intercellular communication through the transfer of genetic material [26–28]. According to ExoCarta, an exosome online database, there are about 8000 proteins known to be related with exosomes. Exosomes have not only specific proteins that depend on cell types but also a subgroup of common and abundant proteins including CD9, CD63, CD81, TSG101, and so on which have been used as positive markers to detect the presence of exosomes regardless of cell types [29, 30]. The specific surface ligands of exosomes ensure that they bind to target cells and deliver their contents, thereby regulating specific biological functions including transmitting intercellular signaling, enhancing angiogenesis, promoting tumor cells proliferation and metastasis, modulating immune responses, and so on [31–33]. Transplantation of exosomes shows similar therapeutic effects and functional properties to directly transplanted stem cells, but there are less significant adverse effects, emphasizing that this treatment strategy could avoid some of the adverse effects seen when transplanting stem cells directly [23, 24, 34]. In recent years, research has focused on the application of MSC-derived exosomes in the field of tissue engineering, inflammation modulation, regeneration medicine etc. [35–38]. Our studies have shown that exosomes derived from MSCs could enhance functional recovery after SCI by inhibiting neuroinflammation and promoting axonal regeneration [39, 40]. A clinical trial was developed to evaluate the effects of MSC-derived exosomes on the possible treatment of type I diabetes mellitus (ClinicalTrials.gov, NCT02138331) and the first patient has successfully been treated with MSC exosomes in graft versus host disease [41]. Oxygen concentration is important in the process of proliferation, differentiation, and self-renewal of MSCs [42, 43]. However, during in vitro culture conditions, MSCs are usually exposed to normoxia (21% O2), which differs from the oxygen concentrations found in the body under natural physiological conditions. A large proportion of MSCs exist in a hypoxic environment (≤ 2–8% O2) in the body. A recent study isolated exosomes from MSCs that were grown in media similar to that found in peripheral arterial disease (0% FBS, 1% O2) and found that the exosomes contained a number of pro-angiogenic factors that may be beneficial to ischemic tissues [43]. A different study, using an infarcted heart model, found that exosomes derived from MSCs after hypoxic treatment, showed increased vascularization, lower apoptosis rates of